Health roundupThursday 15 October 2026

Mpox hits Karachi infant as drug death debate grows

Today's health news spans continents, but two threads stand out: a worrying mpox case in Karachi's youngest patient yet, and a growing international conversation about drug policy and assisted dying. Meanwhile, research on ketamine's anti-inflammatory role offers a fresh angle on treatment-resistant depression.

In today's edition: Infectious disease watch, Mental health and addiction and Policy and care gaps, plus quick bites.

Infectious disease watch

The mpox story continues to evolve, with the youngest case yet in Pakistan raising questions about transmission and surveillance.

sixty.pk

0
Infant boy tests positive for mpox in Karachi

A 40-day-old infant in Karachi tests positive for mpox, marking the city's first case and pushing Sindh's total to 94 this year. The baby is stable but restless, and officials are monitoring the situation. This is a concerning development for a disease that has largely affected adults.

Mental health and addiction

From ketamine's biological mechanisms to policy debates on drug deaths and assisted dying, today's pieces challenge conventional approaches.

talkingketamine.com · 23 min

0
Ketamine and the Inflamed Brain - Talking Ketamine Podcast

This piece digs into the biology of treatment-resistant depression, explaining how inflammation diverts tryptophan into neurotoxic pathways. Ketamine is framed as an 'emergency circuit breaker' that protects synapses, offering a mechanistic reason why it works when standard antidepressants fail.

startsat60.com

0
Andrew Denton: The right to die is not enough

Ten years after his campaign for voluntary assisted dying, Andrew Denton says some Australians are still being denied the right. The piece suggests the legal victory wasn't the end of the fight, and access remains uneven.

Policy and care gaps

Governments and institutions are grappling with how to fund and deliver care, from Australia to Canada.

Quick bites